[CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
Steinert
Tilman
T
Zentrum für Psychiatrie, Die Weissenau, Weingartshoferstr. 2, 88214 Ravensburg. tilman.steinert@zfp-weissenau.de
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016265:Conflict of Interest; D004345:Drug Industry; D005060:Europe; D006801:Humans; D008134:Long-Term Care; D015337:Multicenter Studies as Topic; D017063:Outcome Assessment, Health Care; D010349:Patient Compliance / Q000523:psychology; D017410:Practice Guidelines as Topic; D011358:Product Surveillance, Postmarketing; D011788:Quality of Life / Q000523:psychology; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D055502:Secondary Prevention; D014481:United States
D014150:Antipsychotic Agents